Search results
Apple (NASDAQ:AAPL) Price Target Increased to $245.00 by Analysts at JPMorgan Chase & Co.
ETF DAILY NEWS· 12 hours agoApple (NASDAQ:AAPL – Get Free Report) had its price objective raised by stock analysts at JPMorgan Chase & Co. from $225.00 to $245.00 in a research note ...
Dodge & Cox Reduces Stock Holdings in JPMorgan Chase & Co. (NYSE:JPM)
ETF DAILY NEWS· 4 days agoDodge & Cox reduced its holdings in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 1.5%...
Gateway - Quartz
Quartz· 12 hours agoJPMorgan Chase CEO Jamie Dimon isn’t shaken by the threat of a larger Capital One, backed by its pending $35.3 billion takeover of Discover Financial, which ...
JPMorgan Chase & Co. (NYSE:JPM) Stake Raised by Bradley Foster & Sargent Inc. CT
ETF DAILY NEWS· 6 days agoBradley Foster & Sargent Inc. CT raised its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.6%...
JPMorgan Chase & Co. Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,150.00
ETF DAILY NEWS· 21 hours agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a report issued ...
Willner & Heller LLC Invests $895,000 in JPMorgan Chase & Co. (NYSE:JPM)
ETF DAILY NEWS· 2 days agoWillner & Heller LLC bought a new stake in JPMorgan Chase & Co. (NYSE:JPM) in the fourth quarter,...
JPMorgan Chase & Co. Boosts ON (NYSE:ONON) Price Target to $47.00
ETF DAILY NEWS· 21 hours agoON (NYSE:ONON – Free Report) had its target price raised by JPMorgan Chase & Co. from $40.00 to $47.00 in a research note issued to investors on Monday ...
Bowhead Specialty (NYSE:BOW) Receives New Coverage from Analysts at JPMorgan Chase & Co.
ETF DAILY NEWS· 22 hours agoJPMorgan Chase & Co. initiated coverage on shares of Bowhead Specialty (NYSE:BOW – Free Report) in a...
Clear Street Markets LLC Sells 800 Shares of JPMorgan Chase & Co. (NYSE:JPM)
ETF DAILY NEWS· 6 days agoClear Street Markets LLC decreased its holdings in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by...
Gateway - Quartz
Quartz· 1 hour agoJPMorgan Chase’s asset management division just finished raising a $500 million biotech fund, and its managers are looking at weight loss drug investments ...
